The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico

The CNIC-polypill improves atherogenic dyslipidemia markers in patients at high risk or with cardiovascular disease: Results from a real-world setting in Mexico

Background: In many patients, the risk of cardiovascular (CV) events persists despite statin treatment and attaining target LDL–c levels. This residual risk is in part attributed to atherogenic dyslipidemia (AD). We studied the clinical effectiveness of the CNIC-polypill in improving the lipid profi...

Full description

Bibliographic Details
Main Authors: Enrique Gómez-Álvarez, Juan Verdejo, Salvador Ocampo, Carlos I. Ponte-Negretti, Emilio Ruíz, Marco Martínez Ríos
Format: Article
Language:English
Published: Elsevier 2020-08-01
Series:International Journal of Cardiology: Heart & Vasculature
Subjects:
Polypill
Cardiovascular risk
Lipid ratios
Secondary prevention
High-risk primary prevention
Atherogenic dyslipidemia
Online Access:http://www.sciencedirect.com/science/article/pii/S2352906720301810

Similar Items

Similar Items